4.2 Article

How do hospitalised children die? The context of death and end-of-life decision-making

Journal

JOURNAL OF PAEDIATRICS AND CHILD HEALTH
Volume 59, Issue 4, Pages 625-630

Publisher

WILEY
DOI: 10.1111/jpc.16354

Keywords

advance care planning; child; child mortality; palliative care; withdrawing treatment; withholding treatment

Categories

Ask authors/readers for more resources

This study aims to describe the context of death and end-of-life decision-making in pediatric patients. The results show that in our setting, death of children usually occurs in relation to complex underlying pathology and after the decision of withdrawing or withholding life-sustaining treatment. In this context, palliative care and advance care planning acquire greater importance.
AimThe decrease in childhood mortality, the growing clinical complexity and the greater technification of intensive care units have changed the circumstances of death of paediatric patients. The aim of this study is to describe the context of death and end-of-life decision-making. MethodsSingle-centre, retrospective, observational study of deaths in inpatients or home hospitalised children under 18 years old between 2011 and 2021. Demographic data, pathological history and circumstances of death were obtained from the medical record. The whole study period was divided into two halves for the analysis of the temporal trends. ResultsA total of 358 patients died, 63.2% under the age of 1 year old; 86.9% had underlying life-limiting illnesses and 73.2% died in the intensive care unit, with no differences between the two time periods. Death at home was significantly higher in the second study period (3.8% vs. 9%). A total of 20.1% died during advanced cardiopulmonary resuscitation. Life-sustaining treatment was withheld or withdrawn in 53.6%, with no differences between the time courses. Life-sustaining treatment was withheld mainly in patients with neurological, metabolic and oncological conditions, and less frequently in patients with cardiovascular or respiratory diseases or who were previously healthy. Most patients coded as palliative care (PC) or followed up by PC teams had an advance care plan (ACP) recorded, while in the others it was infrequent. PC coding, following by PC teams and ACP recording increased in the last years of the study. ConclusionsDeath of children in our setting usually occurs in relation to complex underlying pathology and after the decision of withdrawing or withholding life-sustaining treatment. In this context, PC and ACP acquire greater importance. In our study, PC involvement resulted in better documentation of ACP and PC coding.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pediatrics

Clinical management of the acute complications of sickle cell anemia: 11 years of experience in a tertiary hospital

Patricia Reparaz, Idoya Serrano, Rosa Adan-Pedroso, Itziar Astigarraga, Jimena de Pedro Olabarri, Aizpea Echebarria-Barona, Miguel Garcia-Ariza, Ricardo Lopez-Almaraz, Rafael Andres del Orbe-Barreto, Miriam Vara-Pampliega, Paula Gonzalez-Urdiales

Summary: Hospital admissions for acute complications are common in patients with sickle cell disease, with vaso-occlusive crisis and febrile syndrome being the most frequent. These patients require a high use of antibiotics and opioid analgesia. Early diagnosis facilitates the recognition of life-threatening complications.

ANALES DE PEDIATRIA (2022)

Article Pediatrics

Langerhans cell histiocytosis. Advances in pathogenesis and clinical practice

Itziar Astigarraga, Susana Garcia-Obregon, Antonio Perez-Martinez, Ignacio Gutierrez-Carrasco, Vicente Santa-Maria, Carmen Rodriguez-Vigil Iturrate, Mikael Lorite Reggiori, Thais Murciano Carrillo, Montse Torrent

Summary: Langerhans cell histiocytosis (LCH) is a myeloid neoplasia that requires complex diagnosis and treatment. Molecular testing and clinical assessments are essential in determining the extent of the disease and treatment options.

ANALES DE PEDIATRIA (2022)

Article Pediatrics

Oral saliva swab reverse transcription PCR for Covid-19 in the paediatric population

Cinta Moraleda, Sara Dominguez-Rodriguez, Juan Miguel Mesa, Paula Garcia-Sanchez, Maria de la Serna, Jose Antonio Alonso-Cadenas, Amanda Bermejo, Gema Sabrido, Leticia Martinez-Campos, Aranzazu Flavia Gonzalez-Posada, Marta Illan-Ramos, Elena Cobos-Carrascosa, Alvaro Ballesteros, Juan Carlos Galan, Francisco Llorente, David Aguilera-Alonso, Ana Belen Jimenez, Pilar Catalan, Elias Dahdouh, Ignacio Navarro, Barbara Fernandez-Garoz, Pablo Mendoza, Concepcion Perez-Jorge, Teresa Cabezas-Fernandez, Daniel Blazquez-Gamero, Gonzalo Rivas, Patricia Gonzalez-Donapetry, Elena Saez, Jovita Fernandez-Pinero, Jesus Lucas-Fernandez, Elisa Perez-Ramirez, Paloma Merino, Sandra Miragaya, Jorge Lorente, Irene Iglesias, Alfredo Tagarro

Summary: This study evaluated the performance of oral saliva swab (OSS) reverse transcription PCR (RT-PCR) compared with RT-PCR and antigen rapid diagnostic test (Ag-RDT) on nasopharyngeal swabs (NPS) for SARS-CoV-2 in children. The results showed that RT-PCR on the OSS sample is an accurate option for SARS-CoV-2 testing in children, providing a less invasive alternative for younger patients.

ARCHIVES OF DISEASE IN CHILDHOOD (2022)

Article Medicine, General & Internal

Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma

Jaime Gallego Perez-Larraya, Marc Garcia-Moure, Sara Labiano, Ana Patino-Garcia, Jessica Dobbs, Marisol Gonzalez-Huarriz, Marta Zalacain, Lucia Marrodan, Naiara Martinez-Velez, Montserrat Puigdelloses, Virginia Laspidea, Itziar Astigarraga, Blanca Lopez-Ibor, Ofelia Cruz, Miren Oscoz Lizarbe, Sandra Hervas-Stubbs, Gorka Alkorta-Aranburu, Ibon Tamayo, Beatriz Tavira, Ruben Hernandez-Alcoceba, Chris Jones, Gitanjali Dharmadhikari, Cristian Ruiz-Moreno, Henk Stunnenberg, Esther Hulleman, Jasper van der Lugt, Miguel A. Idoate, Ricardo Diez-Valle, Ines Esparragosa Vazquez, Maria Villalba, Carlos de Andrea, Jorge M. Nunez-Cordoba, Brett Ewald, Joan Robbins, Juan Fueyo, Candelaria Gomez-Manzano, Frederick F. Lang, Sonia Tejada, Marta M. Alonso

Summary: This study investigated the use of oncolytic virus DNX-2401 in pediatric patients with diffuse intrinsic pontine glioma (DIPG). The results showed that treatment with DNX-2401 led to changes in T-cell activity and reduction or stabilization of tumor size in some patients, but also caused adverse events.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Oncology

Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T-cell lymphoblastic lymphoma

Julia Salmeron-Villalobos, Joan Enric Ramis-Zaldivar, Olga Balague, Jaime Verdu-Amoros, Veronica Celis, Constantino Sabado, Marta Garrido, Sara Mato, Javier Uriz, M. Jose Ortega, Angela Gutierrez-Camino, Daniel Sinnett, Unai Illarregi, Maxime Carron, Alexandra Regueiro, Ana Galera, Blanca Gonzalez-Farre, Elias Campo, Noelia Garcia, Dolors Colomer, Itziar Astigarraga, Mara Andres, Margarita Llavador, Idoia Martin-Guerrero, Itziar Salaverria

Summary: This study characterized the genetic and molecular heterogeneity of pediatric T-LBL and identified novel molecular markers differentiating it from T-ALL. It found recurrent genetic alterations in pediatric T-LBL, including homozygous deletions of CDKN2A, trisomy 20, and gains of 17q24-q25. The study also revealed novel gene fusions and highlighted the association of Notch pathway alterations with a favorable prognosis in pediatric T-LBL.

PEDIATRIC BLOOD & CANCER (2022)

Review Oncology

Splicing-Disrupting Mutations in Inherited Predisposition to Solid Pediatric Cancer

Piedad Alba-Pavon, Lide Alana, Itziar Astigarraga, Olatz Villate

Summary: Recent studies suggest that at least 10% of pediatric cancer patients carry a germline mutation in a cancer predisposition gene. Splicing mutations play a significant role in the development of pediatric solid tumors, and therapies to correct aberrant splicing in cancer have been developed.

CANCERS (2022)

Article Multidisciplinary Sciences

Identification of germline cancer predisposition variants in pediatric sarcoma patients from somatic tumor testing

Piedad Alba-Pavon, Lide Alana, Miriam Gutierrez-Jimeno, Susana Garcia-Obregon, Teresa Imizcoz, Elena Panizo, Paula Gonzalez-Urdiales, Aizpea Echebarria-Barona, Ricardo Lopez Almaraz, Laura Zaldumbide, Itziar Astigarraga, Ana Patino-Garcia, Olatz Villate

Summary: Genetic predisposition plays a significant role in pediatric cancer, but the relationship between individual genetic mutations and childhood cancer is still being investigated. Sarcomas are often associated with cancer predisposition syndromes, but this is frequently overlooked due to the rarity and heterogeneity of sarcomas and limited search for genetic syndromes. This study identified potential pathogenic germline variants in several genes associated with cancer predisposition syndromes in pediatric sarcoma patients through tumor profiling and sequencing analysis. The results indicate that somatic testing can help identify individuals at risk of underlying cancer predisposition syndromes.

SCIENTIFIC REPORTS (2023)

Meeting Abstract Oncology

LIFE AND END-OF-LIFE AFTER DIFFUSE INTRINSIC PONTINE GLIOMA DIAGNOSIS

Idoya Serrano Pejenaute, Ricardo Lopez-Almaraz, Aizpea Echebarria, Rosa Adan, Jimena De Pedro, Paula Gonzalez, Jesus Sanchez, Julio Lopez-Bayon, Itziar Astigarraga, Miguel Garcia-Ariza

NEURO-ONCOLOGY (2022)

No Data Available